Scripps Research scientists have developed a machine-learning system-;a type of artificial intelligence (AI) application-;that can track the detailed evolution of epidemic viruses and predict the emergence of viral variants with important new properties.
Former Regenxbio leaders take rare disease gene therapies to startup with $15M
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS